[1,1':4',1'':4'',1'''-Quaterphenyl]-3,3''',5,5'''-tetracarbaldehyde, 97%, 100mg

NOTOGINSENOSIDE R1, 98%, 5g

4-chloro-7-(3-chloro-4-methylphenyl)-5-phenyl-7H-pyrrolo[2,3-d]pyrimidine, 95.0%, 250mg

2-(Propylamino)ethanol, 97.0%, 5g

(2E)-3-(2-chloro-6-fluorophenyl)-1-(2,5-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

(R)-Methyl 4-benzylmorpholine-3-carboxylate, 95.0%, 1g

DL-istidina, minimo 98,5%, per biochimica, 100 g, confezione in plastica.

1-Bromo-2-tert-butylbenzene, 95.0%, 25g

Methyl 7-methoxy-4-oxo-1,4-dihydroquinoline-6-carboxylate, 95.0%, 25g

Diiodo(p-cymene)ruthenium(II) dimer, 97%, 5g

6-AMINOQUINOLINE-3-CARBOXYLIC ACID, 95.0%, 250mg

N-(3-methoxybenzyl)-N-methylguanidine sulfate, 95.0%, 5g

4,5-DICHLORO-2-NITROBENZALDEHYDE, 95.0%, 5g